phenoxybenzamine and prednisone

phenoxybenzamine has been researched along with prednisone in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19903 (42.86)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Fries, JF; Miller, JJ1
Kim, WK; Koff, RS1
Marston, A1

Reviews

1 review(s) available for phenoxybenzamine and prednisone

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

6 other study(ies) available for phenoxybenzamine and prednisone

ArticleYear
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Simultaneous vasculitis in a mother and newborn infant.
    The Journal of pediatrics, 1975, Volume: 87, Issue:3

    Topics: Adult; Arthritis; Aspirin; Female; Gangrene; Gentamicins; Heparin; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Meprobamate; Penicillins; Phenoxybenzamine; Prednisone; Pregnancy; Pregnancy Complications, Cardiovascular; Vascular Diseases

1975
Coexistence of raynaud's phenomenon and chronic active hepatitis with hepatitis B antigen.
    Digestion, 1974, Volume: 11, Issue:1-2

    Topics: Adrenergic alpha-Antagonists; Adult; Autoantibodies; Biopsy; Chronic Disease; Hepatitis A; Hepatitis B Antigens; Humans; Immunoelectrophoresis; Liver; Male; Phenoxybenzamine; Prednisone; Raynaud Disease

1974
Gram-negative septicaemia--clinical aspects and physiological management.
    Proceedings of the Royal Society of Medicine, 1969, Dec-12, Volume: 62, Issue:12

    Topics: Central Venous Pressure; Dexamethasone; Drainage; Hemorrhage; Humans; Infusions, Parenteral; Isoproterenol; Phenoxybenzamine; Prednisone; Sepsis; Shock, Septic; Vasoconstrictor Agents

1969